Drug profile · INN
MACI
matrix-applied characterised autologous cultured chondrocytes (MACI) is a may promote synthesis of hyaline-like cartilage repair tissue.
matrix-applied characterised autologous cultured chondrocytes (MACI) is a may promote synthesis of hyaline-like cartilage repair tissue.
May promote synthesis of hyaline-like cartilage repair tissue
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
🔒 Integrated delivery networks in Middle East healthcare: what PwC says about the next phase of care
Scale creates value only when healthcare assets are connected through shared systems, referral flows and coordinated management disciplines
🔒 La Negoziazione del Prezzo dei Farmaci Oncologici in Italia
Italy's 83% reimbursement rate for new cancer medicines (EMA approvals 2019-2022) exceeds the EU average and surpasses France (67%) and Spai…
matrix-applied characterised autologous cultured chondrocytes (MACI) is a may promote synthesis of hyaline-like cartilage repair tissue.
MACI is a marketed brand name for matrix-applied characterised autologous cultured chondrocytes. Check FDA Drugs@FDA for the current US label holder and prescribing information.